Verily Life Sciences, the Alphabet-owned healthcare company, is suspending employee spot bonuses. From a report: The money will be funneled instead to fund diversity and inclusion initiatives. The move frustrated workers, many of whom have been working grueling hours on the company’s COVID-19 testing projects. In a letter to management obtained by Business Insider, employees said the decision implied these initiatives are not a priority. They wrote: “The use of spot bonuses to subsidize social justice programs such as Healthy@Work for HBCUs [Historically Black colleges and universities], clinical trial recruitment of underrepresented populations, and an internal Product Inclusion group implies that these efforts are charity causes not worthy of their own investment.” Employees asked that spot bonuses be reinstated and called for the creation of a board of executives and employees to measure progress toward diversity goals. Alphabet, Verily’s parent company, made $46.07 billion in revenue in the fourth quarter of 2019. Because of Alphabet’s strong financial position, diversity and inclusion shouldn’t be hard to invest in, the employees wrote.
This content was originally published here.